AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

The Beachbody Company, Inc.

$5.23 -$4.19 (-44.48%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$5.55
Day Range
$5.12$5.61
Year Range
$4.05$16.87
Market Cap
37.87M
AVG Volume
49.49K
Trailing/Forward PE
2.97/58.11
PEG ratio
-0.18
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
NASDAQUS
Revenue (USD)
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q249.61M
26 Q154.28M
25 Q455.54M
25 Q359.89M
25 Q263.94M
25 Q172.36M
24 Q486.37M
24 Q3102.19M
24 Q2110.18M
24 Q1120.05M
Net Income (USD)
-40M-30M-20M-10M010M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q21.38M
26 Q12.29M
25 Q45.22M
25 Q33.57M
25 Q2-5.9M
25 Q1-5.75M
24 Q4-34.56M
24 Q3-12M
24 Q2-10.87M
24 Q1-14.22M
Operating Income (USD)
-40M-20M020M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q21.67M
26 Q13.11M
25 Q48.18M
25 Q34.99M
25 Q2-1.47M
25 Q1-3.67M
24 Q4-32.89M
24 Q3-13.01M
24 Q2-9.48M
24 Q1-10.82M
EBITDA (USD)
-20M-10M010M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q24.46M
26 Q16.93M
25 Q410.15M
25 Q38.38M
25 Q2-182K
25 Q11.48M
24 Q4-17.03M
24 Q31.6M
24 Q2377K
24 Q1-2.36M
Cash Flows (USD)
-10M-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-6.21M
26 Q1-1.97M
25 Q44.28M
25 Q39M
25 Q22.42M
25 Q11.65M
24 Q4-7.3M
24 Q353K
24 Q2-2.17M
24 Q17.43M
EPS (USD)
-6-4-20224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.11
26 Q10.3
25 Q40.76
25 Q30.51
25 Q2-0.85
25 Q1-0.84
24 Q4-5.04
24 Q3-1.75
24 Q2-1.59
24 Q1-2.1
Expenses (USD)
025M50M75M100MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q234.84M
26 Q135.69M
25 Q433.87M
25 Q340.86M
25 Q249.53M
25 Q155.92M
24 Q473.22M
24 Q377.76M
24 Q287.1M
24 Q192.16M
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q236.64M
26 Q140.84M
25 Q438.92M
25 Q333.95M
25 Q225.46M
25 Q118.03M
24 Q420.19M
24 Q336.56M
24 Q233.45M
24 Q138.83M
Debt ratios
-2024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Debt ratios by quarter
PeriodDebt ratios
26 Q2-0.39
26 Q1-0.62
25 Q4-0.68
25 Q31.15
25 Q2-0.04
25 Q1-0.11
24 Q4-0.13
24 Q35.24
24 Q20.36
24 Q10.38
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Margins by quarter
PeriodMargins
26 Q272.05%
26 Q170.23%
25 Q474.45%
25 Q374.56%
25 Q272.31%
25 Q171.24%
24 Q470.48%
24 Q367.33%
24 Q269.32%
24 Q167.71%
Return on Capital
-150%-100%-50%0%50%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Return on Capital by quarter
PeriodReturn on Capital
26 Q23.72%
26 Q16.65%
25 Q416.66%
25 Q314.46%
25 Q2-29.27%
25 Q1-23.92%
24 Q4-122.68%
24 Q3-20.56%
24 Q2-16.27%
24 Q1-19.54%
Shares Outstanding
02M4M6M8M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Shares Outstanding by quarter
PeriodShares Outstanding
26 Q27.18M
26 Q17.11M
25 Q46.97M
25 Q37M
25 Q26.92M
25 Q16.88M
24 Q46.86M
24 Q36.84M
24 Q26.81M
24 Q16.76M
Book Value Per Share (USD)
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q25.18
26 Q14.83
25 Q44.49
25 Q33.53
25 Q22.91
25 Q13.49
24 Q44.11
24 Q38.53
24 Q29.8
24 Q110.76
Total Assets (USD)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BODI Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q2136.51M
26 Q1143.13M
25 Q4147.03M
25 Q3146.41M
25 Q2145.89M
25 Q1152.54M
24 Q4174.56M
24 Q3225.47M
24 Q2244.96M
24 Q1263.02M
Employee Count
05001K1.5K202020212022202320242025
BODI Employee Count by quarter
PeriodEmployee Count
2025270
2024355
2023582
2022737
20211.02K
2020494
PE Ratio
05101520med 13.96May 26Jun 26Jul 26Jul 26Aug 26Sep 26
BODI PE Ratio by quarter
PeriodPE Ratio
Sep 263.02
Sep 263.32
Aug 263.37
Aug 263.67
Aug 264.05
Aug 2614.2
Jul 2613.41
Jul 2614.99
Jul 2614.26
Jul 2615.34
Jul 2614.84
Jun 2613.91
Jun 2612.04
Jun 2612.98
Jun 2614
May 2615.04
May 2614.7
May 2615.55
Free Cash Flow Yield
-40%-20%0%20%40%med -6.83%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BODI Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2613.57%
Sep 2612.34%
Aug 2612.15%
Aug 2611.14%
Aug 2610.09%
Aug 2618.68%
Jul 2619.79%
Jul 2617.71%
Jul 2618.61%
Jul 2617.29%
Jul 2617.89%
Jun 2619.07%
Jun 2622.03%
Jun 2620.44%
Jun 2618.96%
May 2617.64%
May 2618.05%
May 2617.06%
May 2618.29%
May 2616.6%
Apr 2616.07%
Apr 2620.37%
Apr 2624.26%
Apr 2620.92%
Mar 2624.33%
Mar 2622.3%
Mar 2623.57%
Mar 269.97%
Feb 2611.85%
Feb 2610.3%
Feb 269.31%
Feb 267.61%
Jan 267.25%
Jan 267.67%
Jan 268.5%
Jan 268.52%
Jan 268.75%
Dec 258.21%
Dec 257.3%
Dec 257.12%
Dec 257.4%
Nov 259.34%
Nov 2510.09%
Nov 2513.15%
Nov 25-9.18%
Oct 25-9.46%
Oct 25-8.08%
Oct 25-8.86%
Oct 25-8.42%
Oct 25-7.86%
Sep 25-7.69%
Sep 25-6.83%
Sep 25-7.12%
Sep 25-7.96%
Aug 25-8.33%
Aug 25-8.48%
Aug 25-8.79%
Aug 25-9.96%
Aug 25-28.86%
Jul 25-24.48%
Jul 25-28.14%
Jul 25-28.14%
Jul 25-26.74%
Jun 25-28.93%
Jun 25-30.42%
Jun 25-29.85%
Jun 25-30.92%
May 25-30.58%
May 25-30.92%
May 25-28.86%
May 25-5.83%
May 25-6.96%
Apr 25-6.61%
Apr 25-7.48%
Apr 25-5.89%
Apr 25-5.3%
Mar 25-3.89%
Mar 25-7.64%
Mar 25-7.89%
Mar 25-8.34%
Feb 25-6.9%
Feb 25-6.84%
Feb 25-8.16%
Feb 25-8.3%
Jan 25-7.33%
Jan 25-7.41%
Jan 25-8.34%
Jan 25-8.35%
Jan 25-8.25%
Dec 24-8.94%
Dec 24-8.73%
Dec 24-8.31%
Dec 24-8.67%
Nov 24-8.46%
Nov 24-8.81%
Nov 24-8.21%
Nov 24-9.96%
Nov 24-10.89%
Oct 24-10.16%
Oct 24-9.67%
Price to Sales
00.10.20.30.40.5med 0.12Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BODI Price to Sales by quarter
PeriodPrice to Sales
Sep 260.17
Sep 260.19
Aug 260.19
Aug 260.21
Aug 260.23
Aug 260.31
Jul 260.3
Jul 260.33
Jul 260.32
Jul 260.34
Jul 260.33
Jun 260.31
Jun 260.27
Jun 260.29
Jun 260.31
May 260.33
May 260.33
May 260.34
May 260.38
May 260.42
Apr 260.43
Apr 260.34
Apr 260.28
Apr 260.33
Mar 260.28
Mar 260.31
Mar 260.29
Mar 260.2
Feb 260.17
Feb 260.2
Feb 260.22
Feb 260.27
Jan 260.28
Jan 260.27
Jan 260.24
Jan 260.24
Jan 260.23
Dec 250.25
Dec 250.28
Dec 250.29
Dec 250.28
Nov 250.22
Nov 250.2
Nov 250.16
Nov 250.11
Oct 250.1
Oct 250.12
Oct 250.11
Oct 250.12
Oct 250.12
Sep 250.13
Sep 250.14
Sep 250.14
Sep 250.12
Aug 250.12
Aug 250.12
Aug 250.11
Aug 250.1
Aug 250.07
Jul 250.09
Jul 250.07
Jul 250.07
Jul 250.08
Jun 250.07
Jun 250.07
Jun 250.07
Jun 250.07
May 250.07
May 250.07
May 250.07
May 250.08
May 250.07
Apr 250.07
Apr 250.06
Apr 250.08
Apr 250.09
Mar 250.12
Mar 250.11
Mar 250.1
Mar 250.1
Feb 250.12
Feb 250.12
Feb 250.1
Feb 250.1
Jan 250.11
Jan 250.11
Jan 250.1
Jan 250.1
Jan 250.1
Dec 240.09
Dec 240.09
Dec 240.1
Dec 240.09
Nov 240.1
Nov 240.09
Nov 240.1
Nov 240.09
Nov 240.09
Oct 240.09
Oct 240.1
EV/EBITDA
050100150med 57.25Feb 21May 21Jul 21Oct 21Apr 26Jun 26Sep 26
BODI EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 260.86
Sep 260.99
Aug 261.01
Aug 261.14
Aug 261.29
Aug 262.28
Jul 262.12
Jul 262.44
Jul 262.3
Jul 262.52
Jul 262.41
Jun 262.22
Jun 261.84
Jun 262.03
Jun 262.24
May 262.46
May 262.39
May 262.56
May 264.1
May 264.59
Apr 264.76
Apr 263.61
Apr 262.92
Apr 263.5
Mar 262.91
Mar 263.24
Mar 263.03
Nov 2124.92
Nov 2122.39
Nov 2152.34
Nov 2155.77
Oct 2159.64
Oct 2155.32
Oct 2160.24
Oct 2160.24
Oct 2165.31
Sep 2174.1
Sep 2185.87
Sep 2180.06
Sep 2194.37
Aug 2173.32
Aug 2175.71
Aug 2172.37
Aug 2184.68
Jul 2185.83
Jul 21103.87
Jul 2175.9
Jul 2191.27
Jul 2194.99
Jun 21114.66
Jun 2195.47
Jun 2199
Jun 2196.71
May 2157.25
May 2156.79
May 2156.56
May 2157.42
Apr 2157.25
Apr 2157.07
Apr 2156.9
Apr 2157.3
Apr 2157.36
Mar 2158.45
Mar 2160.8
Mar 2166.83
Mar 2167.86
Feb 2176.2
Feb 2184.6
Feb 2168.95
Feb 2164.38
Jan 2162.49
Jan 2164.02
Jan 2162.8
Price/Operating Cashflow
050010001500med 17.22Sep 24Jan 25Apr 25Oct 25Feb 26May 26Sep 26
BODI Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 264.46
Sep 264.9
Aug 264.98
Aug 265.43
Aug 265.99
Aug 264.06
Jul 263.83
Jul 264.28
Jul 264.07
Jul 264.38
Jul 264.24
Jun 263.97
Jun 263.44
Jun 263.71
Jun 264
May 264.3
May 264.2
May 264.44
May 264.36
May 264.8
Apr 264.96
Apr 263.92
Apr 263.29
Apr 263.81
Mar 263.28
Mar 263.58
Mar 263.38
Mar 265.77
Feb 264.85
Feb 265.58
Feb 266.18
Feb 267.56
Jan 267.93
Jan 267.5
Jan 266.76
Jan 266.75
Jan 266.57
Dec 257.01
Dec 257.88
Dec 258.07
Dec 257.77
Nov 256.16
Nov 255.7
Nov 254.37
Nov 2537.07
Oct 2535.96
Oct 2542.11
Oct 2538.4
Oct 2540.4
Oct 2543.3
Sep 2544.26
Sep 2549.82
Sep 2547.82
Sep 2542.78
Aug 2540.85
Aug 2540.11
Aug 2538.7
Aug 2534.18
May 2513.25
May 2511.11
Apr 2511.7
Apr 2510.33
Apr 2513.11
Apr 2514.59
Mar 2519.86
Mar 2536.38
Mar 2535.2
Mar 2533.31
Feb 2540.27
Feb 2540.63
Feb 2534.03
Feb 2533.46
Jan 2537.91
Jan 2537.51
Jan 2533.31
Jan 2533.26
Jan 2533.67
Dec 2431.06
Dec 2431.83
Dec 2433.41
Dec 2432.03
Nov 2432.85
Nov 2431.52
Nov 2433.82
Nov 241145.98
Nov 241048.15
Oct 241123.27
Oct 241180.92
Oct 241231.58
Oct 241212.36
Sep 241004.48
Sep 241069.12
Sep 241065.62
Sep 241020.2
Aug 241166.94
Aug 241226.34
Aug 241205.38
Aug 241238.57
Aug 2143.18
Aug 2144.59
Price to Book
01234med 1.78Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BODI Price to Book by quarter
PeriodPrice to Book
Sep 261.01
Sep 261.11
Aug 261.13
Aug 261.23
Aug 261.36
Aug 262.14
Jul 262.02
Jul 262.26
Jul 262.15
Jul 262.31
Jul 262.23
Jun 262.1
Jun 261.81
Jun 261.95
Jun 262.11
May 262.27
May 262.21
May 262.34
May 263.03
May 263.34
Apr 263.45
Apr 262.72
Apr 262.28
Apr 262.65
Mar 262.28
Mar 262.48
Mar 262.35
Mar 262.34
Feb 261.97
Feb 262.27
Feb 262.51
Feb 263.07
Jan 263.23
Jan 263.05
Jan 262.75
Jan 262.74
Jan 262.67
Dec 252.85
Dec 253.2
Dec 253.28
Dec 253.16
Nov 252.5
Nov 252.32
Nov 251.78
Nov 251.72
Oct 251.66
Oct 251.95
Oct 251.78
Oct 251.87
Oct 252
Sep 252.05
Sep 252.31
Sep 252.21
Sep 251.98
Aug 251.89
Aug 251.86
Aug 251.79
Aug 251.58
Aug 251.12
Jul 251.32
Jul 251.15
Jul 251.15
Jul 251.21
Jun 251.12
Jun 251.06
Jun 251.08
Jun 251.05
May 251.06
May 251.05
May 251.12
May 251.2
May 251.01
Apr 251.06
Apr 250.94
Apr 251.19
Apr 251.33
Mar 251.81
Mar 250.83
Mar 250.81
Mar 250.76
Feb 250.92
Feb 250.93
Feb 250.78
Feb 250.77
Jan 250.87
Jan 250.86
Jan 250.76
Jan 250.76
Jan 250.77
Dec 240.71
Dec 240.73
Dec 240.77
Dec 240.73
Nov 240.75
Nov 240.72
Nov 240.77
Nov 240.67
Nov 240.61
Oct 240.66
Oct 240.69
The Beachbody Company, Inc.
BODI
Stockpicker

Video analysis: BODI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BODI

BODi Launches MAX BUILT by Shaun T to Meet Growing Consumer Demand for Strength Training

businesswire.com · 2 Sep 2026

BODi Launches MAX BUILT by Shaun T to Meet Growing Consumer Demand for Strength Training

EL SEGUNDO, Calif.--(BUSINESS WIRE)--BODi (NASDAQ: BODI), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced the launch of MAX BUILT, an all-new nine-week progressive overload strength training program from legendary BODi Super Trainer, Shaun T. As more consumers prioritize building muscle, improving strength, and supporting long-term health, strength training has become one.

Beachbody Details Turnaround, Shakeology Retail Push and P90X Revival at Canaccord Conference

marketbeat.com · 12 Aug 2026

Beachbody Details Turnaround, Shakeology Retail Push and P90X Revival at Canaccord Conference

Beachbody NASDAQ: BODI Executive Chairman Mark Goldston outlined the company's turnaround progress, retail expansion plans and product pipeline at a Canaccord consumer conference, saying the company has shifted away from its former multilevel marketing structure toward a direct-to-consumer and retail-focused wellness strategy.

The Beachbody Company, Inc. (BODI) Q2 2026 Earnings Call Transcript

seekingalpha.com · 10 Aug 2026

The Beachbody Company, Inc. (BODI) Q2 2026 Earnings Call Transcript

The Beachbody Company, Inc. (BODI) Q2 2026 Earnings Call Transcript

The Beachbody Company, Inc. (BODI) Q2 Earnings Beat Estimates

zacks.com · 10 Aug 2026

The Beachbody Company, Inc. (BODI) Q2 Earnings Beat Estimates

The Beachbody Company, Inc. (BODI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to a loss of $0.57 per share a year ago.

Beachbody Q2 Earnings Call Highlights

marketbeat.com · 10 Aug 2026

Beachbody Q2 Earnings Call Highlights

Beachbody NASDAQ: BODI reported second-quarter 2026 revenue of $49.6 million, exceeding the midpoint of its guidance range, while extending its streak of positive operating income, net income and adjusted EBITDA as the company continues shifting toward a nutrition-led, multi-channel model.

Beachbody (BODi) Reports Second Quarter Financial Results

businesswire.com · 10 Aug 2026

Beachbody (BODi) Reports Second Quarter Financial Results

EL SEGUNDO, Calif.--(BUSINESS WIRE)--The Beachbody Company, Inc. (NASDAQ: BODi) (“BODi” or the “Company”), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced financial results for its second quarter ended June 30, 2026. “Q2 marks our fourth consecutive quarter of net income and operating income, further validating the strength of our transformed business model,” said Carl Dai.

BODi Announces Second Amendment to Credit Facility

businesswire.com · 6 Aug 2026

BODi Announces Second Amendment to Credit Facility

EL SEGUNDO, Calif.--(BUSINESS WIRE)--The Beachbody Company, Inc. (NASDAQ: BODI) ("BODi" or the "Company"), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced it has entered into a second amendment to its credit agreement with Tiger Finance, LLC, as administrative agent and collateral agent. This modification continues to enhance the Company's financial flexibility through ame.

BODi Expands Retail Presence with Shakeology Now Available at The Vitamin Shoppe Nationwide; Launches New Flavor

businesswire.com · 6 Aug 2026

BODi Expands Retail Presence with Shakeology Now Available at The Vitamin Shoppe Nationwide; Launches New Flavor

EL SEGUNDO, Calif.--(BUSINESS WIRE)--BODi (NASDAQ: BODI), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced that Shakeology is now available at The Vitamin Shoppe locations nationwide. The Vitamin Shoppe launch reinforces BODi's commitment to making science-backed wellness more accessible to consumers across the U.S. The retail rollout includes the core flavors of Shakeology.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.